Elder Pharmaceuticals Ltd.
BSE: 532322 | Sector: Health care |
NSE: ELDERPHARM | ISIN Code: INE975A01015 |
BSE 00:00 | 04 Mar | Elder Pharmaceuticals Ltd |
NSE 05:30 | 01 Jan | Elder Pharmaceuticals Ltd |
OPEN | 115.70 |
PREVIOUS CLOSE | 112.70 |
VOLUME | 8920 |
52-Week high | 115.70 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 231 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Elder Pharmaceuticals Ltd. (ELDERPHARM) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 636.95 | 3.69 | 653.70 | 388.60 | 152823.41 |
Divi's Lab. | 3751.15 | 0.95 | 3913.00 | 1924.00 | 99574.28 |
Dr Reddy's Labs | 4759.50 | 1.48 | 5514.65 | 3200.00 | 79150.49 |
Cipla | 882.30 | 4.82 | 892.00 | 452.25 | 71153.08 |
Aurobindo Pharma | 943.65 | 4.04 | 1023.10 | 393.75 | 55288.45 |
Cadila Health. | 514.55 | 9.32 | 517.75 | 290.10 | 52674.48 |
Biocon | 420.30 | 1.72 | 487.70 | 298.05 | 50436.00 |
Lupin | 1079.60 | 3.01 | 1121.85 | 670.00 | 48981.45 |
Apollo Hospitals | 3133.30 | 0.61 | 3283.90 | 1212.90 | 45050.59 |
Torrent Pharma. | 2573.40 | 0.96 | 3040.00 | 2143.55 | 43547.08 |
Gland Pharma | 2530.00 | 0.69 | 2784.45 | 1701.00 | 41390.80 |
Piramal Enterp. | 1809.55 | 0.36 | 2008.20 | 805.60 | 40814.40 |
Alkem Lab | 2832.25 | 4.66 | 3150.00 | 2223.55 | 33859.55 |
Abbott India | 15245.80 | 1.32 | 18569.00 | 13970.10 | 32397.32 |
Ipca Labs. | 2085.10 | 1.04 | 2455.55 | 1442.65 | 26449.49 |
Dr Lal Pathlabs | 3139.20 | 0.33 | 3232.85 | 1390.00 | 26162.09 |
Glaxosmi. Pharma | 1445.80 | 1.46 | 1805.00 | 1177.25 | 24493.30 |
Laurus Labs | 421.75 | 0.31 | 429.90 | 71.38 | 22631.10 |
Syngene Intl. | 560.00 | 0.38 | 644.65 | 262.35 | 22400.00 |
Pfizer | 4797.80 | 3.88 | 5875.00 | 3940.00 | 21949.94 |
Quick Links for Elder Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices